Industries - Regenerative Medicine Market Analysis by Product Type (Tissue-engineered Products, Cell Therapies, Gene Therapies, Stem Cell Therapies), by Therapeutic Area (Musculoskeletal, Dermatology, Oncology, Immunology & Inflammation, Ophthalmology, Cardiovascular), and by Region – Forecast to 2026

Ablation Technology Market Analysis

Regenerative Medicine Market Analysis by Product Type (Tissue-engineered Products, Cell Therapies, Gene Therapies, Stem Cell Therapies), by Therapeutic Area (Musculoskeletal, Dermatology, Oncology, Immunology & Inflammation, Ophthalmology, Cardiovascular), and by Region – Forecast to 2026
July 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Regenerative Medicine Market Analysis by Product Type (Tissue-engineered Products, Cell Therapies, Gene Therapies, Stem Cell Therapies), by Therapeutic Area (Musculoskeletal, Dermatology, Oncology, Immunology & Inflammation, Ophthalmology, Cardiovascular), and by Region - Forecast to 2026

Published: July-21 | Historical Data: 2018-2020 | Base Year: 2020
SKU:ICI-HC-1330| Number of Pages: 160 | Category: Pharmaceuticals

” The global regenerative medicine market size is projected to reach USD 55.1 billion by 2026, exhibiting a compounded annual growth rate (CAGR) of 27.5% during the forecast period 2020-2026.”

Regenerative medicine applies engineering and life science principle to replace or regenerate human cells, tissues, or organs to restore normal function. Regenerative medicine technique has been successfully used to replace damaged skin, cartilage, urethra, bladder, blood vessels, kidney, liver, ear and trachea. Regenerative medicine is useful in various therapeutic category like dermatology, musculoskeletal, immunology and inflammation, oncology, cardiovascular disease, and ophthalmology. Tissue engineering and biomaterials engineered substances are useful in regenerative medicine to supplement and replace our natural body function. Regenerative medicine enhances the recovery speed of the patient by reducing the risk of organ rejection by body after transplantation. Advances in regenerative medicine have potential to treat chronic diseases and condition such as Alzheimer, Parkinson’s, diabetes, osteoporosis, and spinal cord injury, among others.

Rise in funding from government and private investors for clinical research and development is driving the regenerative medicine market growth globally. Efficient product development pertains a strong well-established product pipeline with least possible adverse effects, thereby making the pharmaceutical & biotechnological firms to continually evolve their R&D operations. Factors such as increasing chronic disease cases, demand for advanced medication, patent support programs, and outbreak of Covid-19 pandemic are also driving the global market growth. According to the World Health Organization (WHO), cardiovascular disease has remained the leading cause of death for the last 20 years globally and responsible for 16% of the world’s total deaths. As per Centres for Disease Control and Prevention (CDC), in the U.S. 34.2 million people have diabetes, out of which 26.9 million people are diagnosed and 7.3 million people are undiagnosed. However, ethical and patent right concerns associated with embryonic stem cells, inadequate technical knowledge, and cost constraints for R&D are expected to hinder the growth.

Regenerative Medicine Market

Read more about the market dynamics, Request a Sample Copy

Market Driver Analysis

Rising investment in regenerative medicine production and research development to drive market growth

Regenerative medicine market is booming due to increased investment by key market players and government organizations in the development of regenerative medicines. For instance, in 2018, approximately USD 13.3 billion global financing was invested in regenerative medicine research and development. Companies are focusing on developing novel products using advance technology are investing huge amounts in clinical trials. Approximately, as of 2020, a total of 1,220 clinical trial studies related to regenerative medicine were conducted globally. Additionally, in 2018, Novartis received approval for Luxturna from the European Union, a gene therapy product developed to treat vision issues in people with rare and genetically associated retinal diseases.

Increased prevalence of genetic disorders and chronic illness stimulating the market growth

Regenerative medicine has applications in a wide range of therapeutic categories. Increasing prevalence of chronic illness such as diabetes, cardiovascular disease, cancer, and genetic disorders are further escalating the demand for regenerative medicine market. For instance, in 2020, almost three quarters of the total deaths globally were due to chronic diseases. In developing countries, 71% of deaths were due to ischemic heart disease, 75% of deaths were due to stroke, while 70% occurred due to diabetes. According to WHO, in 2020, approximately 10 million people died due to cancer while 28.4 million new cancer cases are projected to occur by 2040 globally. Increasing awareness among people regarding the available stem cells process and its benefits is stimulating the demand for regenerative medicines globally.

Market Segmentation and Share Analysis

By Product Type

Based on product type, the market is categorized into tissue-engineered products, cell therapies, gene therapies, and progenitor & stem cell therapies. In 2020, the cell therapies product segment accounted for the highest revenue share of the global regenerative medicine market. Early adoption of cell-based therapies and its wide application makes it a large revenue generating segment. The progenitor & stem cell therapies segment is the expected to grow at a fastest CAGR during the forecast period owing to increasing investments in stem cell technology and liberalizing regulatory landscape for use of stem cells in treating medical conditions.

By Therapeutic Area

Based on therapeutic area, the market is segmented into musculoskeletal, dermatology, oncology, immunology & inflation, ophthalmology, cardiovascular, and others. In 2020, dermatology market segment accounted for the largest revenue share owing to large application of regenerative medicines in this segment. The oncology segment is projected to be the fastest growing segment due to increasing cases of cancer and rising clinical trials for oncology drugs.

Regional Insights

North America was the highest revenue-grossing segment of the global market in 2020 and is projected to maintain its dominance during the forecast period.  This is due to the presence of large pharmaceutical & biotechnology companies and novel drug development. Companies located in North America are making considerable investment in novel technologies such as gene therapies, tissue engineering, stem cell banking and drug discovery.

North America Regenerative Medicine Market Size (2018-2026), USD Million

North America Regenerative Medicine Market

Read more about the market dynamics, Request a Sample Copy

The Asia Pacific market is estimated to grow at the fastest growth rate during the forecast period owing to the heavy investments in medical infrastructure and research activities with favourable government support for stem cell technology approval. For instance, the Chinese government approved several research activities related to human embryonic stem cell to explore clinical potential of stem cells in the country.

Competitor Insights

Some of the major companies in the regenerative medicine market are F. Hoffmann-La Roche AG (Switzerland); Baxter International Inc. (U.S.); Merck & Co., Inc. (U.S.); Integra LifeSciences Holdings Corporation (U.S.); Pfizer Inc. (U.S.); MiMedx Group (U.S.); AstraZeneca plc (U.K.); Corestem (South Korea); Zimmer Biomet (U.S.); and Takeda Pharmaceutical Company Limited (Japan). Ongoing product developments, investment in R&D, improvement in clinical management process, and strategic collaborations & acquisitions are some of the major strategies adopted by the leading players operating in the industry.

Industry Developments

  • In February 2020, Integra Lifesciences launched AminoEcxel Plus, a next generation trilayer placental allograft membrane which helps to repair, reconstruct and replace wound tissue.
  • In March 2019, Smith and Nephew announced the acquisition of Osiris Therapeutics Inc., a regenerative medicine products company to accelerate wound management business.

Research Scope and Segments

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The regenerative medicine market report is categorized into the following segments and subsegments:

Regenerative Medicine Market, By Product Type (Revenue, 2018-2026, USD Million)

  • Tissue-engineered Products
  • Cell Therapies
    • Autologous Therapies
    • Allogenic Therapies
  • Gene Therapies
  • Progenitor & Stem Cell Therapies

Regenerative Medicine Market, By Therapeutic Area (Revenue, 2018-2026, USD Million)

  • Musculoskeletal
  • Dermatology
  • Oncology
  • Immunology & Inflammation
  • Ophthalmology
  • Cardiovascular
  • Others

Regenerative Medicine Market, By Region (Revenue, 2018-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Regenerative Medicine Market Report:

Key Parameters Details
Data Availability 2018-2026
Historical Years 2018-2020
Base Year Considered 2020
Forecast Data 2021-2026
Company Profiles 10
Companies Considered (Across Value Chain) >40
Value Units Value in USD and CAGR in %
Market Segments Product Type and Therapeutic Area
Regional Coverage
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players
  • Hoffmann-La Roche AG
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Integra LifeSciences
  • Pfizer Inc.
  • MiMedx Group
  • AstraZeneca plc
  • Corestem
  • Zimmer Biomet
  • Takeda Pharmaceutical Company Limited
Custom Analysis Customization up to 60 analyst hours (15%)

Regenerative Medicine Market, By Product Type (Revenue, 2018-2026, USD Million)

  • Tissue-engineered Products
  • Cell Therapies
    • Autologous Therapies
    • Allogenic Therapies
  • Gene Therapies
  • Progenitor & Stem Cell Therapies

Regenerative Medicine Market, By Therapeutic Area (Revenue, 2018-2026, USD Million)

  • Musculoskeletal
  • Dermatology
  • Oncology
  • Immunology & Inflammation
  • Ophthalmology
  • Cardiovascular
  • Others

Regenerative Medicine Market, By Region (Revenue, 2018-2026, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Rising adoption for personalized medication
  3.1.2. Increasing prevalence of genetic disorders and chronic illness
  3.1.3. Growing stringency in product quality
  3.1.4. Heavy investment in regenerative medicine production & research
 3.2. Market Restraint Analysis
  3.2.1. Ethical concerns associated with embryonic stem cells
  3.2.2. Inadequate technical know-how and cost constraints for R&D
 3.3. Market Opportunities
  3.3.1. Growing awareness for regenerative medicines in emerging economies
  3.3.2. Increasing organ transplant surgeries
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2018-2020)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2026)
6. Regenerative Medicine Market Size and Forecast, by Product Type (2018-2026), USD Million
 6.1. Tissue-engineered Products
 6.2. Cell Therapies
  6.2.1. Autologous Therapies
  6.2.2. Allogenic Therapies
 6.3. Gene Therapies
 6.4. Progenitor & Stem Cell Therapies
7. Regenerative Medicine Market Size and Forecast, by Therapeutic Area (2018-2026), USD Million
 7.1. Musculoskeletal
 7.2. Dermatology
 7.3. Oncology
 7.4. Immunology & Inflammation
 7.5. Ophthalmology
 7.6. Cardiovascular
 7.7. Others
8. Regenerative Medicine Market, Regional Analysis (2018-2026), USD Million
 8.1. North America
  8.1.1. Introduction
   8.1.1.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.1.1.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
   8.1.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.1.2. U.S.
   8.1.2.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.1.2.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.1.3. Canada
   8.1.3.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.1.3.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
 8.2. Europe
  8.2.1. Introduction
   8.2.1.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.1.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
   8.2.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.2.2. Germany
   8.2.2.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.2.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.3. UK
   8.2.3.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.3.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.4. France
   8.2.4.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.4.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.5. Spain
   8.2.5.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.5.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.6. Italy
   8.2.6.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.6.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.7. Russia
   8.2.7.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.7.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.2.8. Rest of Europe
   8.2.8.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.2.8.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
 8.3. Asia Pacific (APAC)
  8.3.1. Introduction
   8.3.1.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.1.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
   8.3.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.3.2. China
   8.3.2.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.2.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.3.3. Japan
   8.3.3.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.3.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.3.4. India
   8.3.4.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.4.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.3.5. Australia
   8.3.5.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.5.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.3.6. South Korea
   8.3.6.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.6.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.3.7. Rest of Asia Pacific
   8.3.7.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.3.7.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
 8.4. Latin America (LATAM)
  8.4.1. Introduction
   8.4.1.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.4.1.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
   8.4.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.4.2. Brazil
   8.4.2.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.4.2.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.4.3. Mexico
   8.4.3.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.4.3.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.4.4. Argentina
   8.4.4.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.4.4.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.4.5. Rest of LATAM
   8.4.5.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.4.5.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
 8.5. Middle East & Africa (MEA)
  8.5.1. Introduction
   8.5.1.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.5.1.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
   8.5.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
  8.5.2. South Africa
   8.5.2.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.5.2.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.5.3. Saudi Arabia
   8.5.3.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.5.3.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
  8.5.4. Rest of MEA
   8.5.4.1. Market Size & Forecast, by Product Type (2018-2026), USD Million
   8.5.4.2. Market Size & Forecast, by Therapeutic Area (2018-2026), USD Million
9. Competitor Analysis
 9.1. Market Player Comparison
 9.2. Product-wise Player Mapping
 9.3. Region-wise Player Mapping
 9.4. Market Share Analysis
 9.5. Market Position Analysis
 9.6. Recent Development Analysis
10. Company Profiles
 10.1. F. Hoffmann-La Roche AG (Switzerland)
  10.1.1. Company Overview
  10.1.2. Company Financials
  10.1.3. Product Portfolio
  10.1.4. Recent Developments
 10.2. Baxter International Inc. (U.S.)
  10.2.1. Company Overview
  10.2.2. Company Financials
  10.2.3. Product Portfolio
  10.2.4. Recent Developments
 10.3. Merck & Co., Inc. (U.S.),
  10.3.1. Company Overview
  10.3.2. Company Financials
  10.3.3. Product Portfolio
  10.3.4. Recent Developments
 10.4. Integra LifeSciences Holdings Corporation (U.S.)
  10.4.1. Company Overview
  10.4.2. Company Financials
  10.4.3. Product Portfolio
  10.4.4. Recent Developments
 10.5. Pfizer Inc. (U.S.)
  10.5.1. Company Overview
  10.5.2. Company Financials
  10.5.3. Product Portfolio
  10.5.4. Recent Developments
 10.6. MiMedx Group (U.S.)
  10.6.1. Company Overview
  10.6.2. Company Financials
  10.6.3. Product Portfolio
  10.6.4. Recent Developments
 10.7. AstraZeneca plc (U.K.)
  10.7.1. Company Overview
  10.7.2. Company Financials
  10.7.3. Product Portfolio
  10.7.4. Recent Developments
 10.8. Corestem (South Korea)
  10.8.1. Company Overview
  10.8.2. Company Financials
  10.8.3. Product Portfolio
  10.8.4. Recent Developments
 10.9. Zimmer Biomet (U.S.)
  10.9.1. Company Overview
  10.9.2. Company Financials
  10.9.3. Product Portfolio
  10.9.4. Recent Developments
 10.10. Takeda Pharmaceutical Company Limited (Japan)
  10.10.1. Company Overview
  10.10.2. Company Financials
  10.10.3. Product Portfolio
  10.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

Historic Period: 2018-2020, Base Year: 2020, Forecast Data: 2021-2026

Regenerative medicine market exhibits a compounded annual growth rate (CAGR) of 27.5% from 2020 to 2026

Prominent players in the regenerative medicine market are F. Hoffmann-La Roche AG, Baxter International Inc., Merck & Co., Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., MiMedx Group, AstraZeneca plc, Corestem, Zimmer Biomet, and Takeda Pharmaceutical Company Limited.

Asia Pacific and North America offers numerous growth opportunities for companies operating in the Regenerative medicine market

Cell therapies segment leads the Product market segment in 2020

Yes, the report offers comprehensive analysis of the COVID-19 pandemic on the market. The report comes with in-depth deviation analysis pre- and post-COVID-19 along with the market trends during the study period.

We follow our in-house domain-assisted cognition (DAC) research framework to compose all our market research reports. The framework ensures contextually relevant insights discovery by collecting precise market information via primary and secondary research.

Yes, we offer 15% free customization with the purchase of this report. Please Contact Us regarding your customization requirements and our research expert will connect with you within 12 hours.


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Regenerative Medicine Market Analysis by Product Type (Tissue-engineered Products, Cell Therapies, Gene Therapies, Stem Cell Therapies), by Therapeutic Area (Musculoskeletal, Dermatology, Oncology, Immunology & Inflammation, Ophthalmology, Cardiovascular), and by Region - Forecast to 2026